TD-198946 acts as a potent and selective inhibitor of the human epidermal growth factor receptor (EGFR), falling within the pyrazolo-pyrimidine class of kinase inhibitors. This agent targets signal transduction… Read more
TD-198946 acts as a potent and selective inhibitor of the human epidermal growth factor receptor (EGFR), falling within the pyrazolo-pyrimidine class of kinase inhibitors. This agent targets signal transduction pathways to inhibit tumor growth and is utilized in research concerning the treatment of non-small cell lung cancer, colorectal cancer, and glioblastoma. Analytical laboratories require highly specific related compounds to support the rigorous quality control and characterization of this substance. The associated impurities, metabolites, and stable isotope-labelled standards provided in this category are essential for accurate impurity profiling and method validation. By utilizing these precise reference materials, researchers can reliably identify degradation products and ensure the chemical integrity of the parent drug during high-resolution analytical testing and regulatory documentation processes.